Granules India Ltd is Rated Buy

2 hours ago
share
Share Via
Granules India Ltd is rated 'Buy' by MarketsMojo, with this rating last updated on 06 April 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 06 August 2026, providing investors with an up-to-date view of the company’s performance and prospects.
Granules India Ltd is Rated Buy

Current Rating and Its Significance

MarketsMOJO’s 'Buy' rating for Granules India Ltd indicates a positive outlook on the stock, suggesting that investors may consider adding it to their portfolios based on its current fundamentals and market behaviour. This rating reflects a comprehensive evaluation of the company’s quality, valuation, financial trends, and technical indicators, all of which contribute to the overall investment thesis.

Quality Assessment

As of 06 August 2026, Granules India Ltd demonstrates strong operational quality. The company holds a 'good' quality grade, supported by a high return on capital employed (ROCE) of 16.82%, signalling efficient use of capital to generate profits. Additionally, the firm maintains a low Debt to EBITDA ratio of 1.28 times, underscoring its robust ability to service debt and maintain financial stability. The management’s efficiency is further reflected in consistent positive quarterly results, with the latest six months’ profit after tax (PAT) reaching ₹369.30 crores, marking a growth of 41.39%.

Valuation Considerations

While the valuation grade is currently marked as 'expensive', this reflects the premium investors are willing to pay for Granules India Ltd’s growth prospects and market position. The stock’s price-to-earnings ratio and other valuation metrics suggest that the market has priced in strong future earnings potential. Investors should weigh this premium against the company’s demonstrated ability to deliver consistent earnings growth and operational efficiency.

Financial Trend Analysis

The financial trend for Granules India Ltd is positive, with the latest data showing strong sales and profitability momentum. Quarterly net sales have reached a record high of ₹1,476.77 crores, while the operating profit to interest coverage ratio stands at an impressive 16.05 times, indicating ample earnings to cover interest expenses. The company’s positive trajectory is also evident in its market-beating returns, with a 1-year return of 94.74% and a 6-month return of 51.60%, significantly outperforming the broader BSE500 index over multiple time frames.

Technical Outlook

From a technical perspective, Granules India Ltd is rated as 'bullish'. The stock has shown steady upward momentum, with recent price movements reflecting investor confidence. The 1-day gain of 1.31% and 1-week gain of 2.44% reinforce this positive trend. Technical indicators suggest that the stock remains in an uptrend, supported by strong volume and institutional buying.

Institutional Confidence

Institutional investors hold a significant 33.61% stake in Granules India Ltd, a factor that often signals confidence in the company’s fundamentals and growth prospects. Notably, institutional holdings have increased by 1.29% over the previous quarter, indicating growing interest from sophisticated market participants who typically conduct rigorous fundamental analysis before committing capital.

Market Performance and Investor Implications

Granules India Ltd’s market performance has been impressive, with returns of 94.74% over the past year and consistent outperformance relative to the BSE500 index over the last three years, one year, and three months. This strong track record, combined with solid fundamentals and a bullish technical outlook, supports the current 'Buy' rating. For investors, this suggests that the stock offers attractive growth potential, albeit at a premium valuation, and may be suitable for those with a medium to long-term investment horizon.

Here's How the Stock Looks TODAY

As of 06 August 2026, Granules India Ltd continues to demonstrate robust financial health and operational strength. The company’s ability to generate high returns on capital, maintain low leverage, and deliver consistent profit growth underpins its investment appeal. Despite the 'expensive' valuation grade, the positive financial trend and bullish technical signals provide a compelling case for investors seeking exposure to the Pharmaceuticals & Biotechnology sector.

Our latest monthly pick, this Small Cap from Oil Exploration/Refineries, is showing strong performance since announcement! See why our Investment Committee chose it after screening 50+ candidates.

  • - Investment Committee approved
  • - 50+ candidates screened
  • - Strong post-announcement performance

See Why It Was Chosen →

Sector and Market Context

Operating within the Pharmaceuticals & Biotechnology sector, Granules India Ltd benefits from favourable industry dynamics, including increasing demand for generic formulations and active pharmaceutical ingredients. The company’s strategic positioning and operational efficiency enable it to capitalise on these trends. Its small-cap status offers potential for significant growth, though investors should remain mindful of sector-specific risks such as regulatory changes and competitive pressures.

Summary for Investors

In summary, Granules India Ltd’s 'Buy' rating by MarketsMOJO reflects a balanced assessment of its strong quality metrics, positive financial trends, and bullish technical outlook, despite a relatively expensive valuation. The company’s consistent earnings growth, efficient capital utilisation, and increasing institutional interest make it an attractive proposition for investors seeking growth opportunities in the pharmaceutical space. As always, investors should consider their risk tolerance and investment horizon when evaluating this stock.

Looking Ahead

Going forward, Granules India Ltd’s ability to sustain its growth momentum and manage valuation expectations will be key factors influencing its market performance. Continued operational excellence and favourable sector conditions could further enhance shareholder value. Investors are advised to monitor quarterly results and market developments closely to make informed decisions.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News